Search for 'glucose monitoring'

Search in texts for 'glucose monitoring' - Neurosonology.net'

Download page (1)

10 results of 3 texts with exact phrase : 'glucose monitoring'.

1. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 11, 2015, No. 2 , , ,

Continuous glucose monitoring (CGM) performs multiple blood glucose measurements and is used for defining the control and changing the treatment regimen in diabetic patients, especially those with varying glucose levels and experiencing frequent hypoglycemic episodes.
Continuous glucose monitoring (CGM) performs multiple blood glucose measurements and is used for defining the control and changing the treatment regimen in diabetic patients, especially those with varying glucose levels and experiencing frequent hypoglycemic episodes. iPro 2
read the entire text >>

Professional is a forth generation continuous glucose monitoring system, valuable for detecting high and low glucose fluctuations and is small enough for patient to forget they have it on.
Professional is a forth generation continuous glucose monitoring system, valuable for detecting high and low glucose fluctuations and is small enough for patient to forget they have it on. iPro2 Professional CGM uses a tiny glucose sensor to record 288 glucose readings over a 24-hour period. Glucose data are captured in the system and are uploaded to CareLink iPro Software. The reports are useful for educating and motivating patients to implement changes in their diabetes management after viewing what effects specific foods, exercise, stress and medications have on their glucose levels.
read the entire text >>

Combining insulin pump technology with continuous blood glucose monitoring system improves real-time control of the blood sugar level.
The continuous subcutaneous insulin infusion therapy (insulin pump) is a medical device used for the administration of short acting insulin and is thought to be the most physiological way for insulin replacement. Recently it is used not only in type 1, but also in type 2 diabetes. Combining insulin pump technology with continuous blood glucose monitoring system improves real-time control of the blood sugar level. Closing the loop will allow the system to function as an artificial pancreas.
read the entire text >>

2. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 13, 2017, No. 1 , , ,

Avoidance of hypoglycemia requires frequent glucose monitoring; in many hospitals this necessitates admission to an intensive care unit, which may otherwise not be needed
Similar to the high blood pressure, there are several detrimental effects of hyperglycemia, such as tissue acidosis, increased blood–brain barrier permeability, decreased vascular reactivity, and risk of hemorrhagic transformation, which are most probably pathophysiological substrates of poor outcome in stroke patients with hyperglycemia. First studies considering the effect of hyperglycemia on stroke outcome have been conducted on animal models [25]; there are many studies and much evidence that acute hyperglycemia predicts increased risk of in-hospital mortality and poor functional recovery after AIS in non-diabetic stroke survivors. This conclusion has been made by Capes and his colleagues, after a literature review of 32 studies [23, 26]. However, currently there is no clinical evidence that targeting the blood glucose to a particular level during AIS will improve outcomes. The main risk from aggressive hyperglycemia correction is the possible hypoglycemia. Avoidance of hypoglycemia requires frequent glucose monitoring; in many hospitals this necessitates admission to an intensive care unit, which may otherwise not be needed
read the entire text >>

3. NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, vol. 14, 2018, No. 2 , , ,

Novel Methods for Continuing Glucose Monitoring.
Novel Methods for Continuing Glucose Monitoring.
read the entire text >>

CONTINUOUS GLUCOSE MONITORING OF BLOOD SUGARS – A ROLE OF NEW TECHNOLOGIES IN DIABETIC PATIENT FOLLOW-UP
CONTINUOUS GLUCOSE MONITORING OF BLOOD SUGARS – A ROLE OF NEW TECHNOLOGIES IN DIABETIC PATIENT FOLLOW-UP
read the entire text >>

Various methods are used to determine the degree of disease control: measuring blood glucose alone, determining glycated hemoglobin and other glycated proteins, continuous 24-hour glucose monitoring for different time period.
The incidence of diabetes mellitus is increasing significantly recent decades and exceeding so far the expectations, and despite the current treatment and follow-up options, a large number of patients do not achieve the desired therapeutic goals. Various methods are used to determine the degree of disease control: measuring blood glucose alone, determining glycated hemoglobin and other glycated proteins, continuous 24-hour glucose monitoring for different time period.
read the entire text >>

Continuous glucose monitoring (CGM) is a device used to measure glucose in the inerstiual fluid at a certain time interval over a different period.
Continuous glucose monitoring (CGM) is a device used to measure glucose in the inerstiual fluid at a certain time interval over a different period. The information is stored in a special memory or displayed on the device screen. The method is minimally invasive and involves measuring glucose concentrations in the interstitial and converting these values to blood sugar levels. Most currently used devices are consisting of an enzyme-coated electrode (sensor), most commonly a glucooxidase. A large number of modern monitoring systems have the ability to synchronize with devices for continuous subcutaneous insulin infusion (insulin pumps) to adjust the dose regimen and optimize their effectiveness.
read the entire text >>

diabetis mellitus, glucose monitoring, new technologies
diabetis mellitus, glucose monitoring, new technologies
read the entire text >>

не (continuous glucose monitoring, CGM) включва устройства, замерващи глюкозата в инерстициума през определен интервал от време в продължение на различен период.
не (continuous glucose monitoring, CGM) включва устройства, замерващи глюкозата в инерстициума през определен интервал от време в продължение на различен период. Информацията се запазва в специална памет или се представя на екрана на устройството. Методът е минимално инвазивен, измерва глюкозни концентрации в интерстициума и конвертира тези стойности към кръвно-захарни нива. Повечето съвременни устройства използват електрод (сензор) с ензимно покритие, най-често глюкооксидаза. Голяма част от мониториращите системи имат възможност за синхронизиране с устройства за постоянна подкожна инсулинова инфузия (инсулинови помпи), с което се прецизира дозовия режим и се оптимизира ефективността им. Понастоящем най-често използвани, с доказана надеждност и безопасност, са следните типове системи – iPro (Medtronic), Guardian-REAL-Time/ Paradigm-REAL-Time (Medtronic), FreeStyle Navigator (Abbott), Dexcom G4, G5 (Dexcom).
read the entire text >>

Back to Top